Bruker is a performace leader in preclinical imaging instrumentation. Bruker offers nine imaging modalities: PET, SPECT, CT, MRI, MPI, fluorescence, luminiscence, radioisotipic imaging and X-ray.
Discover
Back to filter
Show all topics (10)
Related topics
Understand the Cancer Ecosystem based on single cells analysis
Sep 22, 2022
Mission Bio is a life sciences company that accelerates discoveries and cures for a wide range of diseases by equipping...
Automating DNA Extraction for High-Throughput Bacterial Plasmid Purification with CyBi®-SELMA
Sep 19, 2022
The Need to Increase Plasmid Isolation Throughput, Challenges with Scaling up Plasmid DNA Extraction, Automating the...
Introducing RareCyte Orion, integrating Spatial Biology with Multiplex Imaging
Sep 13, 2022
Orion, the highly multiplexed fluorescent imaging system, empower investigators to unlock spatial context for key...
Cytek Aurora at CIVIS Summer School
Aug 23, 2022
OMIXYS´s workshop during CIVIS project for spectral flowcytometry, using Aurora from Cytek
xCELLigence eSight - Imaging & Impedance in real-time inside your incubator
Aug 22, 2022
The xCELLigence RTCA eSight enables comprehensive insight into cell health, cell behavior, cell function and cell...
Standardize tumor sample preparation and reduce background with Curiox laminar wash system
Aug 10, 2022
Laminar Wash technology offers a gentle alternative that can improve yield and data quality, particularly of rare cell...
Developing a 43 color panel on Cytek Aurora using Laminar Wash for sample prep
Aug 2, 2022
Successfully executing a 43 color panel is a technically demanding task. One that is made more difficult when there are...
Transcriptome-Informed Approach to Drug Discovery
Jul 12, 2022
The HTG EdgeSeq system is a powerful molecular profiling tool for biopharmaceutical companies, academic research...
Semi-automated genomic DNA extractionfrom Plant with CyBi®-SELMA
Jul 12, 2022
Plant genomic DNA extraction with CyBio SELMA, Semi-Automated Pipette with minimal benchtop footprint
New Center of Excellence, located at the Josep Carreras Leukaemia Research Institute
Jul 12, 2022
Mission Bio is a life sciences company that accelerates discoveries and cures for a wide range of diseases by equipping...
Optical radionuclide imaging strategies for preclinical studies
Apr 13, 2017
Preclinical imaging is a key step in a variety of scientific endeavors, including basic understanding of biological processes and pharmaceutical research and development. Two common classes of preclinical molecular imaging methods are (1) optical techniques, including fluorescence and bioluminescence, and (2) nuclear techniques, including PET, SPECT, as well as new optical imaging techniques discussed in this note. In many cases, the goal of preclinical molecular imaging is to look at the uptake, distribution, or interaction of a specific targeted molecule in vivo. These agents are typically referred to as probes or tracers in optical and nuclear imaging, respectively.
These agents are typically labeled or tagged with a distinguishing moiety in order to actively track them. However, fluorescent tags can be large relative to the target molecule of interest. On the other hand, radiolabeling typically has very little or no effect on the molecular shape, size, or function of a tagged molecule and many radionuclides can be directly incorporated into the native structure of the molecule of interest.
Related technologies: Fluorescence, luminescence, X-ray, radiographic imaging
Brand profile
